跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
RISPERIDONE BNM risperidone 1 mg/mL oral liquid solution bottle
Approved
STANDARD
RISPERIDONE BNM risperidone 1 mg/mL oral liquid solution bottle
Boucher & Muir Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
c60ac7b57a80232e
Company
Boucher & Muir Pty Ltd
Type
Standard
Approval Details
Approval Id
c60ac7b57a80232e
Product Name
RISPERIDONE BNM risperidone 1 mg/mL oral liquid solution bottle
Artg Id
299573
Artg Name
RISPERIDONE BNM risperidone 1 mg/mL oral liquid solution bottle
Sponsor
Boucher & Muir Pty Ltd
Company Detail Path
/organization/boucher-and-muir-pty-ltd
Artg Date
2018-12-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
c60ac7b57a80232e
Type
Standard
Back to TGA Approvals
RISPERIDONE BNM risperidone 1 mg/mL oral liquid solution bottle - TGA Drug Approval Details
